BioMedNewsBreaks – United Medical Equipment Business Solutions Network Inc. Offers Unique Mobile Solution

United Medical Equipment (“UME,” “UMEBSNI”) has committed to help speed economic recovery by supplying rapid COVID-19 test kits. In addition, the company has even gone a step further by offering “a unique mobile solution that involves on-call onsite COVID-19 Rapid Testing Mobile units,” reads a recent article. This offering is regarded as essential during the pandemic. “These units involve mobile testing specialists and experienced medical staff members who provide onsite COVID-19 rapid testing. Capable of nationwide deployment for extended periods, they are especially beneficial for securing employee safety.”

To view the full article, visit https://ibn.fm/5n61f

About United Medical Equipment Business Solutions Network Inc.

United Medical Equipment Business Solutions Network offers reliable resources and solutions that are designed to meet the ever-changing needs of an aging population, which includes seniors and veterans. The company’s owners and founders bring decades of combined business, military and cardiovascular critical care nursing experience. United Medical Equipment understands the needs and concerns of the aging population, including veterans and their families, and offers the support, solutions and reliable information critical in making informed decisions. UMEs’ mission is to provide guidance for caregivers, veterans, the aging population and medical community through its medication management and telehealth applications by providing reliable resources, products and support services designed to meet unique needs. For more information, visit the company’s website at www.UnitedMedSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to UME are available in the company’s newsroom at https://ibn.fm/UnitedMed

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Reports Strong Correlation for Finger-Prick Nu.Q NETs Prototype in Sepsis Patients 

VolitionRx Limited (NYSE American: VNRX), a multinational epigenetics company, announced that results using its lateral flow finger-prick prototype…

2 hours ago

BioMedNewsBreaks — Nano-X Imaging Ltd. (NASDAQ: NNOX) Optimizes Nanox.AI Medical Imaging Framework for Intel Core Ultra Processors 

Nano-X Imaging Ltd. (NASDAQ: NNOX) announced that subsidiary Nanox AI Ltd. has optimized its medical imaging AI application framework for…

23 hours ago

BioMedNewsBreaks — AOM Capital Completes $5.1 Million Financing for Therapeutics Company Acquisition 

AOM Capital announced the completion of a $5.1 million financing for a therapeutics company in connection…

24 hours ago

BioMedNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS into Phase 2

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid…

2 days ago

BioMedNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Q2 Revenue of $13.5 Million as TONMYA Sales Reach $11 Million

Tonix Pharmaceuticals (NASDAQ: TNXP) reported second-quarter 2026 net product revenue of approximately $13.5 million, up…

2 days ago

BioMedNewsBreaks — Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones

Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory…

5 days ago